In 2018, Shi et al. established that the promoter of the PITX1 gene was hypermethylated, and the expression levels of downstream products were markedly reduced in patients with AIS compared to those in controls (Shi et al., 2018). This evidence concerns the gene PITX1 and androgen insensitivity syndrome.